- Home
- BDRX vs SXTP Comparison
BDRX vs SXTP Comparison
Compare BDRX & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDRX
- SXTP
- Stock Information
- Founded
- BDRX 2000
- SXTP 2010
- Country
- BDRX United Kingdom
- SXTP United States
- Employees
- BDRX N/A
- SXTP N/A
- Industry
- BDRX Biotechnology: Pharmaceutical Preparations
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- BDRX Health Care
- SXTP Health Care
- Exchange
- BDRX Nasdaq
- SXTP Nasdaq
- Market Cap
- BDRX 2.4M
- SXTP 2.7M
- IPO Year
- BDRX N/A
- SXTP 2023
- Fundamental
- Price
- BDRX $4.28
- SXTP $0.83
- Analyst Decision
- BDRX Strong Buy
- SXTP Hold
- Analyst Count
- BDRX 1
- SXTP 1
- Target Price
- BDRX $200.00
- SXTP N/A
- AVG Volume (30 Days)
- BDRX 16.1K
- SXTP 967.9K
- Earning Date
- BDRX 09-30-2024
- SXTP 11-14-2024
- Dividend Yield
- BDRX N/A
- SXTP N/A
- EPS Growth
- BDRX N/A
- SXTP N/A
- EPS
- BDRX N/A
- SXTP N/A
- Revenue
- BDRX $104,895.00
- SXTP $462,612.00
- Revenue This Year
- BDRX N/A
- SXTP $141.35
- Revenue Next Year
- BDRX N/A
- SXTP $175.16
- P/E Ratio
- BDRX N/A
- SXTP N/A
- Revenue Growth
- BDRX N/A
- SXTP 128.99
- 52 Week Low
- BDRX $3.50
- SXTP $0.70
- 52 Week High
- BDRX $74.00
- SXTP $10.67
- Technical
- Relative Strength Index (RSI)
- BDRX 47.13
- SXTP 36.41
- Support Level
- BDRX $4.13
- SXTP $0.87
- Resistance Level
- BDRX $4.60
- SXTP $0.95
- Average True Range (ATR)
- BDRX 0.25
- SXTP 0.14
- MACD
- BDRX 0.04
- SXTP -0.06
- Stochastic Oscillator
- BDRX 55.15
- SXTP 6.99
About BDRX Biodexa Pharmaceuticals plc American Depositary Shs
Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.